SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001842952-23-000054
Filing Date
2023-05-10
Accepted
2023-05-10 16:34:58
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cntx-20230331.htm   iXBRL 10-Q 610850
2 EX-31.1 cntx2023-033110xqexhibit311.htm EX-31.1 10846
3 EX-31.2 cntx2023033110-qexhibit312.htm EX-31.2 10849
4 EX-32.1 cntx2023033110-qexhibit321.htm EX-32.1 6598
  Complete submission text file 0001842952-23-000054.txt   3167458

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cntx-20230331.xsd EX-101.SCH 24510
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cntx-20230331_cal.xml EX-101.CAL 27418
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cntx-20230331_def.xml EX-101.DEF 96072
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cntx-20230331_lab.xml EX-101.LAB 333795
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cntx-20230331_pre.xml EX-101.PRE 203060
44 EXTRACTED XBRL INSTANCE DOCUMENT cntx-20230331_htm.xml XML 386611
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40654 | Film No.: 23907100
SIC: 2834 Pharmaceutical Preparations